Editorial: Precision oncology in checkpoint immunotherapy: leveraging predictive biomarkers for personalized treatment 21 de January de 2026 by Zodwa Dlamini
Editorial: Ubiquitination in tumor pathogenesis and progression and its therapeutic potential 21 de January de 2026 by Asif Amin Dar
Editorial: Novel therapeutic targets in autoimmune diseases: intestinal microbiota and adaptive immunity regulation 20 de January de 2026 by Caio César de Souza Alves
Editorial: Roles of macrophages and monocytes in resistance to immunotherapy in cancers 19 de January de 2026 by Guillaume Mestrallet
Editorial: Strategies aimed at improving the effectiveness of immunotherapies in pediatric brain cancer 19 de January de 2026 by Samuele Tardito
Editorial: Interdisciplinary innovations in CAR T-cell therapy for autoimmune and cancer treatment 16 de January de 2026 by Apostolos Zaravinos
Editorial: Decoding tumor plasticity: integrative analysis of epigenetic regulation and microenvironmental adaptation 16 de January de 2026 by Ran Wang
Editorial: Thymus biology: development, immunodeficiency and cancer progression 16 de January de 2026 by Yongfeng He
Editorial: Risk and protective factors in the natural history of autoimmunity 16 de January de 2026 by Christine G. Parks
Editorial: Hunting for inflammation mediators: identifying novel biomarkers for autoimmune and autoinflammatory diseases 13 de January de 2026 by Li Zeng
